Literature DB >> 19470506

Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Silke Feuerriegel1, Helen S Cox, Nana Zarkua, Hamraev A Karimovich, Kai Braker, Sabine Rüsch-Gerdes, Stefan Niemann.   

Abstract

The rapid detection of Mycobacterium tuberculosis isolates resistant to second-line drugs is crucial for the institution of appropriate treatment regimens as early as possible. Although molecular methods have successfully been used for the rapid detection of resistance to first-line drugs, there are limited data on mutations that confer resistance to second-line drugs. To address this question, we analyzed Mycobacterium tuberculosis strains resistant to ofloxacin (n = 26) and to capreomycin and/or amikacin (n = 48) from Uzbekistan for variations in target genes (gyrA, gyrB, rrs, and tlyA). Strains susceptible to ofloxacin (n = 49) and capreomycin and/or amikacin (n = 39) were included as controls. Mutations in gyrA or gyrB were found in 96% (25/26 strains) of the ofloxacin-resistant strains, while none of the susceptible strains displayed mutations in those two genes. The most common mutation occurred in gyrA at codon 94 (17/26 strains [65.4%]), followed by mutations at codons 90 and 91. Two strains showed a mutation in gyrB, at codons 485 and 543, respectively; both mutations have not been reported previously. The most frequent mutation in strains resistant to both amikacin and capreomycin was A1401G in rrs (34/40 strains [85.0%]). Three strains had mutations in tlyA, of which two (at codons 18 and 118) were associated with resistance to capreomycin alone. Overall, none of the 10 resistant strains (5 amikacin-resistant and capreomycin-susceptible strains) and none of the 39 susceptible control strains had mutations in the genes investigated. Our results clearly demonstrate the potential of sequence analyses of short regions of relatively few target genes for the rapid detection of resistance to second-line drugs among strains isolated from patients undergoing treatment for multidrug-resistant tuberculosis. The mechanisms that confer amikacin resistance in this setting remain unclear.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470506      PMCID: PMC2715645          DOI: 10.1128/AAC.00050-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Authors:  G E Pfyffer; D A Bonato; A Ebrahimzadeh; W Gross; J Hotaling; J Kornblum; A Laszlo; G Roberts; M Salfinger; F Wittwer; S Siddiqi
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Heteroresistance in Mycobacterium tuberculosis.

Authors:  H Rinder; K T Mieskes; T Löscher
Journal:  Int J Tuberc Lung Dis       Date:  2001-04       Impact factor: 2.373

3.  DNA sequencing with chain-terminating inhibitors. 1977.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Biotechnology       Date:  1992

4.  Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.

Authors:  Helen S Cox; Katia Sibilia; Silke Feuerriegel; Stobdan Kalon; Jonny Polonsky; Atadjan K Khamraev; Sabine Rüsch-Gerdes; Clair Mills; Stefan Niemann
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

5.  Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis.

Authors:  G J Alangaden; B N Kreiswirth; A Aouad; M Khetarpal; F R Igno; S L Moghazeh; E K Manavathu; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

6.  Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene.

Authors:  Y Suzuki; C Katsukawa; A Tamaru; C Abe; M Makino; Y Mizuguchi; H Taniguchi
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis.

Authors:  D van Soolingen; P W Hermans; P E de Haas; D R Soll; J D van Embden
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

8.  Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.

Authors:  H E Takiff; L Salazar; C Guerrero; W Philipp; W M Huang; B Kreiswirth; S T Cole; W R Jacobs; A Telenti
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis.

Authors:  Maria Rosalia Pasca; Paola Guglierame; Fabio Arcesi; Marco Bellinzoni; Edda De Rossi; Giovanna Riccardi
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

10.  Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.

Authors:  T Kocagöz; C J Hackbarth; I Unsal; E Y Rosenberg; H Nikaido; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more
  46 in total

Review 1.  A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.

Authors:  Fernanda Maruri; Timothy R Sterling; Anne W Kaiga; Amondrea Blackman; Yuri F van der Heijden; Claudine Mayer; Emmanuelle Cambau; Alexandra Aubry
Journal:  J Antimicrob Chemother       Date:  2012-01-25       Impact factor: 5.790

2.  Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Authors:  Florence Brossier; Nicolas Veziris; Alexandra Aubry; Vincent Jarlier; Wladimir Sougakoff
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

3.  Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.

Authors:  Florence Brossier; Anne Pham; Christine Bernard; Alexandra Aubry; Vincent Jarlier; Nicolas Veziris; Wladimir Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.

Authors:  Li-Li Zhao; Yan Chen; Hai-Can Liu; Qiang Xia; Xiao-Cui Wu; Qing Sun; Xiu-Qin Zhao; Gui-Lian Li; Zhi-Guang Liu; Kang-Lin Wan
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

5.  PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data.

Authors:  Silke Feuerriegel; Viola Schleusener; Patrick Beckert; Thomas A Kohl; Paolo Miotto; Daniela M Cirillo; Andrea M Cabibbe; Stefan Niemann; Kurt Fellenberg
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

6.  Multiplex detection of extensively drug resistant tuberculosis using binary deoxyribozyme sensors.

Authors:  Hillary N Bengtson; Susanne Homolka; Stefan Niemann; Ana Júlia Reis; Pedro Eduardo da Silva; Yulia V Gerasimova; Dmitry M Kolpashchikov; Kyle H Rohde
Journal:  Biosens Bioelectron       Date:  2017-03-01       Impact factor: 10.618

7.  DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.

Authors:  Alix Pantel; Stéphanie Petrella; Stéphanie Matrat; Florence Brossier; Sylvaine Bastian; Delphine Reitter; Vincent Jarlier; Claudine Mayer; Alexandra Aubry
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

8.  Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.

Authors:  Rashid Akbergenov; Dmitri Shcherbakov; Tanja Matt; Stefan Duscha; Martin Meyer; Daniel N Wilson; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

9.  Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae.

Authors:  Kazumasa Yokoyama; Hyun Kim; Tetsu Mukai; Masanori Matsuoka; Chie Nakajima; Yasuhiko Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

10.  Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Authors:  Hum Nath Jnawali; Heekyung Yoo; Sungweon Ryoo; Kwang-Jun Lee; Bum-Joon Kim; Won-Jung Koh; Chang-Ki Kim; Hee-Jin Kim; Young Kil Park
Journal:  World J Microbiol Biotechnol       Date:  2013-01-18       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.